Kellogg Will Use Monsanto's Low Linolenic Soybean Oil
Filed in archive Food and Agriculture on December 14, 2005

Kellogg, one of the biggest cereal and convenience food manufacturer, will reformulate some of its products to make use of soybean oil from Monsanto's Vistive(R) soybeans, in an effort to reduce or eliminate trans fatty acids in a number of its products.
What are Vistive soybeans?
These soybeans, produced using marker-assisted breeding, have low levels of linolenic acid. Soybeans low in linolenic acid reduce or eliminate the need for partial hydrogenation, a process routinely used to increase shelf life and flavor stability in fried foods, baked goods, snack products, and other processed foods. The partial-hydrogenation process also creates trans fatty acids in the foods. These trans fats are linked to heart disease, because they raise LDL (bad) cholesterol while lowering HDL (good) cholesterol.
Beginning next year, food manufacturers in the US will be required to to label the trans fat content of their products. By using Vistive-soybean oil, food manufacturers such as Kellogg will be able to show low trans-fat content in their products, ergo, a healthier profile.
Read more from the Food Navigator USA.

Tags: cereals cholesterol biotech soybean linolenic monsanto+linolenic linolenic+soybean food+agriculture
Vote for Kellogg Will Use Monsanto's Low Linolenic Soybean Oil:
|
Rating: 8.63 out of 8 vote(s) cast.
|
Response from:
mina
(12/15/05 12:21pm)
Cereals are healthy eats. And I am happy that there are still ways to make it healthier.
Response from:
ruth
(12/19/05 7:14pm)
Thank you for dropping a note, Mina. Let's hope Monsanto's low-lin soybean oil also makes it to other products as well.
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
